Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1111357
PUBLISHER: IMARC | PRODUCT CODE: 1111357
Cancer Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
PUBLISHED:
PAGES: 147 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global cancer biomarkers market reached a value of US$ 21.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 47.66 Billion by 2027, exhibiting a CAGR of 13.20% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Cancer biomarkers are biological molecules that indicate the presence of cancerous cells in the blood, tissues or other fluids of the body. They can be produced by the cancer cell itself or by other tissues in the body in response to cancer. Some common forms of cancer include breast, prostate, cervical, lung, and colorectal cancer. They are widely used for diagnosing the disease, monitoring their progression, distinguishing between invasive and non-invasive tumors, predicting the chances of recurrences and recording therapeutic treatment efficacy. Enzymes, proteins, nucleic acids, genes, specific cells. and peptides are some of the common types of biomarkers. As a result, they are widely used as prognostics, surrogate endpoints, diagnostics, and personalized medicines.
Cancer Biomarkers Market Trends:
- The increasing prevalence of cancer across the globe is creating a positive outlook for the market. Biomarkers are widely used for early cancer detection and during treatment and management to accurately and reliably predict outcomes. In line with this, the increasing incidences of lung cancer due to the upsurge in pollution levels, smoking trends and poor ingestion habits is augmenting the market growth. Moreover, various technological advancements in genetic biomarker discovery, such as next-generation sequencing (NGS), polymerase chain reaction (PCR), gene expression profiling (microarray), and the artificial inelegance (AI) that assist in predicting the recurrence of cancer after treatment, are providing an impetus to the market growth. Additionally, the increasing awareness amongst healthcare professionals and patients about the importance of early diagnosis and the significant shift toward personalized medicine for cancer treatment due to the lack of standard diagnosis is favoring the market growth. Other factors, including the significant growth in the healthcare industry, extensive research and development (R&D) activities and the implementation of various government initiatives for enhancing the drug development processes, are anticipated to drive the market toward growth.
Key Market Segmentation:
- IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer biomarkers market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on profiling technology, biomolecule, cancer type, application and end user.
Breakup by Profiling Technology:
- Omic Technologies
- Imaging Technologies
- Immunoassays
- Cytogenetics
Breakup by Biomolecule:
- Genetic Biomarkers
- Protein Biomarkers
- Glyco-Biomarkers
Breakup by Cancer Type:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Stomach Cancer
- Others
Breakup by Application:
- Diagnostics
- Prognostics
- Risk Assessment
- Drug Discovery and Development
- Others
Breakup by End User:
- Hospitals
- Academic and Research Institutions
- Ambulatory Surgical Centers
- Diagnostic Laboratories
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
- The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, bioMerieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, General Electric Company, Illumina Inc., Qiagen N.V., Sino Biological Inc. and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
- How has the global cancer biomarkers market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global cancer biomarkers market?
- What are the key regional markets?
- What is the breakup of the market based on the profiling technology?
- What is the breakup of the market based on the biomolecule?
- What is the breakup of the market based on the cancer type?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global cancer biomarkers market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR0822A55_Report
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Cancer Biomarkers Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Profiling Technology
- 6.1 Omic Technologies
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Imaging Technologies
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Immunoassays
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Cytogenetics
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Biomolecule
- 7.1 Genetic Biomarkers
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Protein Biomarkers
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Glyco-Biomarkers
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Cancer Type
- 8.1 Breast Cancer
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Lung Cancer
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Colorectal Cancer
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Prostate Cancer
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Stomach Cancer
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
9 Market Breakup by Application
- 9.1 Diagnostics
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Prognostics
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Risk Assessment
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Drug Discovery and Development
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
- 9.5 Others
- 9.5.1 Market Trends
- 9.5.2 Market Forecast
10 Market Breakup by End User
- 10.1 Hospitals
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Academic and Research Institutions
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
- 10.3 Ambulatory Surgical Centers
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
- 10.4 Diagnostic Laboratories
- 10.4.1 Market Trends
- 10.4.2 Market Forecast
- 10.5 Others
- 10.5.1 Market Trends
- 10.5.2 Market Forecast
11 Market Breakup by Region
- 11.1 North America
- 11.1.1 United States
- 11.1.1.1 Market Trends
- 11.1.1.2 Market Forecast
- 11.1.2 Canada
- 11.1.2.1 Market Trends
- 11.1.2.2 Market Forecast
- 11.1.1 United States
- 11.2 Asia-Pacific
- 11.2.1 China
- 11.2.1.1 Market Trends
- 11.2.1.2 Market Forecast
- 11.2.2 Japan
- 11.2.2.1 Market Trends
- 11.2.2.2 Market Forecast
- 11.2.3 India
- 11.2.3.1 Market Trends
- 11.2.3.2 Market Forecast
- 11.2.4 South Korea
- 11.2.4.1 Market Trends
- 11.2.4.2 Market Forecast
- 11.2.5 Australia
- 11.2.5.1 Market Trends
- 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
- 11.2.6.1 Market Trends
- 11.2.6.2 Market Forecast
- 11.2.7 Others
- 11.2.7.1 Market Trends
- 11.2.7.2 Market Forecast
- 11.2.1 China
- 11.3 Europe
- 11.3.1 Germany
- 11.3.1.1 Market Trends
- 11.3.1.2 Market Forecast
- 11.3.2 France
- 11.3.2.1 Market Trends
- 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
- 11.3.3.1 Market Trends
- 11.3.3.2 Market Forecast
- 11.3.4 Italy
- 11.3.4.1 Market Trends
- 11.3.4.2 Market Forecast
- 11.3.5 Spain
- 11.3.5.1 Market Trends
- 11.3.5.2 Market Forecast
- 11.3.6 Russia
- 11.3.6.1 Market Trends
- 11.3.6.2 Market Forecast
- 11.3.7 Others
- 11.3.7.1 Market Trends
- 11.3.7.2 Market Forecast
- 11.3.1 Germany
- 11.4 Latin America
- 11.4.1 Brazil
- 11.4.1.1 Market Trends
- 11.4.1.2 Market Forecast
- 11.4.2 Mexico
- 11.4.2.1 Market Trends
- 11.4.2.2 Market Forecast
- 11.4.3 Others
- 11.4.3.1 Market Trends
- 11.4.3.2 Market Forecast
- 11.4.1 Brazil
- 11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast
12 SWOT Analysis
- 12.1 Overview
- 12.2 Strengths
- 12.3 Weaknesses
- 12.4 Opportunities
- 12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
- 14.1 Overview
- 14.2 Bargaining Power of Buyers
- 14.3 Bargaining Power of Suppliers
- 14.4 Degree of Competition
- 14.5 Threat of New Entrants
- 14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
- 16.1 Market Structure
- 16.2 Key Players
- 16.3 Profiles of Key Players
- 16.3.1 Abbott Laboratories
- 16.3.1.1 Company Overview
- 16.3.1.2 Product Portfolio
- 16.3.1.3 Financials
- 16.3.1.4 SWOT Analysis
- 16.3.2 Agilent Technologies Inc.
- 16.3.2.1 Company Overview
- 16.3.2.2 Product Portfolio
- 16.3.2.3 Financials
- 16.3.2.4 SWOT Analysis
- 16.3.3 Becton Dickinson and Company
- 16.3.3.1 Company Overview
- 16.3.3.2 Product Portfolio
- 16.3.3.3 Financials
- 16.3.3.4 SWOT Analysis
- 16.3.4 bioMerieux SA
- 16.3.4.1 Company Overview
- 16.3.4.2 Product Portfolio
- 16.3.4.3 Financials
- 16.3.4.4 SWOT Analysis
- 16.3.5 Danaher Corporation
- 16.3.5.1 Company Overview
- 16.3.5.2 Product Portfolio
- 16.3.5.3 Financials
- 16.3.5.4 SWOT Analysis
- 16.3.6 F. Hoffmann-La Roche AG
- 16.3.6.1 Company Overview
- 16.3.6.2 Product Portfolio
- 16.3.6.3 SWOT Analysis
- 16.3.7 General Electric Company
- 16.3.7.1 Company Overview
- 16.3.7.2 Product Portfolio
- 16.3.7.3 Financials
- 16.3.7.4 SWOT Analysis
- 16.3.8 Illumina Inc.
- 16.3.8.1 Company Overview
- 16.3.8.2 Product Portfolio
- 16.3.8.3 Financials
- 16.3.8.4 SWOT Analysis
- 16.3.9 Qiagen N.V.
- 16.3.9.1 Company Overview
- 16.3.9.2 Product Portfolio
- 16.3.9.3 Financials
- 16.3.9.4 SWOT Analysis
- 16.3.10 Sino Biological Inc.
- 16.3.10.1 Company Overview
- 16.3.10.2 Product Portfolio
- 16.3.11 Thermo Fisher Scientific Inc.
- 16.3.11.1 Company Overview
- 16.3.11.2 Product Portfolio
- 16.3.11.3 Financials
- 16.3.11.4 SWOT Analysis
- 16.3.1 Abbott Laboratories
Product Code: SR0822A55_Report
List of Figures
- Figure 1: Global: Cancer Biomarkers Market: Major Drivers and Challenges
- Figure 2: Global: Cancer Biomarkers Market: Sales Value (in Billion US$), 2016-2021
- Figure 3: Global: Cancer Biomarkers Market Forecast: Sales Value (in Billion US$), 2022-2027
- Figure 4: Global: Cancer Biomarkers Market: Breakup by Profiling Technology (in %), 2021
- Figure 5: Global: Cancer Biomarkers Market: Breakup by Biomolecule (in %), 2021
- Figure 6: Global: Cancer Biomarkers Market: Breakup by Cancer Type (in %), 2021
- Figure 7: Global: Cancer Biomarkers Market: Breakup by Application (in %), 2021
- Figure 8: Global: Cancer Biomarkers Market: Breakup by End User (in %), 2021
- Figure 9: Global: Cancer Biomarkers Market: Breakup by Region (in %), 2021
- Figure 10: Global: Cancer Biomarkers (Omic Technologies) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 11: Global: Cancer Biomarkers (Omic Technologies) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 12: Global: Cancer Biomarkers (Imaging Technologies) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 13: Global: Cancer Biomarkers (Imaging Technologies) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 14: Global: Cancer Biomarkers (Immunoassays) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 15: Global: Cancer Biomarkers (Immunoassays) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 16: Global: Cancer Biomarkers (Cytogenetics) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 17: Global: Cancer Biomarkers (Cytogenetics) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 18: Global: Cancer Biomarkers (Genetic Biomarkers) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 19: Global: Cancer Biomarkers (Genetic Biomarkers) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 20: Global: Cancer Biomarkers (Protein Biomarkers) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 21: Global: Cancer Biomarkers (Protein Biomarkers) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 22: Global: Cancer Biomarkers (Glyco-Biomarkers) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 23: Global: Cancer Biomarkers (Glyco-Biomarkers) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 24: Global: Cancer Biomarkers (Breast Cancer) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 25: Global: Cancer Biomarkers (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 26: Global: Cancer Biomarkers (Lung Cancer) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 27: Global: Cancer Biomarkers (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 28: Global: Cancer Biomarkers (Colorectal Cancer) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 29: Global: Cancer Biomarkers (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 30: Global: Cancer Biomarkers (Prostate Cancer) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 31: Global: Cancer Biomarkers (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 32: Global: Cancer Biomarkers (Stomach Cancer) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 33: Global: Cancer Biomarkers (Stomach Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 34: Global: Cancer Biomarkers (Other Cancer Types) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 35: Global: Cancer Biomarkers (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 36: Global: Cancer Biomarkers (Diagnostics) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 37: Global: Cancer Biomarkers (Diagnostics) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 38: Global: Cancer Biomarkers (Prognostics) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 39: Global: Cancer Biomarkers (Prognostics) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 40: Global: Cancer Biomarkers (Risk Assessment) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 41: Global: Cancer Biomarkers (Risk Assessment) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 42: Global: Cancer Biomarkers (Drug Discovery and Development) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 43: Global: Cancer Biomarkers (Drug Discovery and Development) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 44: Global: Cancer Biomarkers (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 45: Global: Cancer Biomarkers (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 46: Global: Cancer Biomarkers (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 47: Global: Cancer Biomarkers (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 48: Global: Cancer Biomarkers (Academic and Research Institutions) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 49: Global: Cancer Biomarkers (Academic and Research Institutions) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 50: Global: Cancer Biomarkers (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 51: Global: Cancer Biomarkers (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 52: Global: Cancer Biomarkers (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 53: Global: Cancer Biomarkers (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 54: Global: Cancer Biomarkers (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 55: Global: Cancer Biomarkers (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 56: North America: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
- Figure 57: North America: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 58: United States: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
- Figure 59: United States: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 60: Canada: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
- Figure 61: Canada: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 62: Asia-Pacific: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
- Figure 63: Asia-Pacific: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 64: China: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
- Figure 65: China: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 66: Japan: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
- Figure 67: Japan: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 68: India: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
- Figure 69: India: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 70: South Korea: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
- Figure 71: South Korea: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 72: Australia: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
- Figure 73: Australia: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 74: Indonesia: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
- Figure 75: Indonesia: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 76: Others: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
- Figure 77: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 78: Europe: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
- Figure 79: Europe: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 80: Germany: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
- Figure 81: Germany: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 82: France: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
- Figure 83: France: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 84: United Kingdom: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
- Figure 85: United Kingdom: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 86: Italy: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
- Figure 87: Italy: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 88: Spain: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
- Figure 89: Spain: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 90: Russia: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
- Figure 91: Russia: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 92: Others: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
- Figure 93: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 94: Latin America: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
- Figure 95: Latin America: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 96: Brazil: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
- Figure 97: Brazil: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 98: Mexico: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
- Figure 99: Mexico: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 100: Others: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
- Figure 101: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 102: Middle East and Africa: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
- Figure 103: Middle East and Africa: Cancer Biomarkers Market: Breakup by Country (in %), 2021
- Figure 104: Middle East and Africa: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 105: Global: Cancer Biomarkers Industry: SWOT Analysis
- Figure 106: Global: Cancer Biomarkers Industry: Value Chain Analysis
- Figure 107: Global: Cancer Biomarkers Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Cancer Biomarkers Market: Key Industry Highlights, 2021 and 2027
- Table 2: Global: Cancer Biomarkers Market Forecast: Breakup by Profiling Technology (in Million US$), 2022-2027
- Table 3: Global: Cancer Biomarkers Market Forecast: Breakup by Biomolecule (in Million US$), 2022-2027
- Table 4: Global: Cancer Biomarkers Market Forecast: Breakup by Cancer Type (in Million US$), 2022-2027
- Table 5: Global: Cancer Biomarkers Market Forecast: Breakup by Application (in Million US$), 2022-2027
- Table 6: Global: Cancer Biomarkers Market Forecast: Breakup by End User (in Million US$), 2022-2027
- Table 7: Global: Cancer Biomarkers Market Forecast: Breakup by Region (in Million US$), 2022-2027
- Table 8: Global: Cancer Biomarkers Market: Competitive Structure
- Table 9: Global: Cancer Biomarkers Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.